Explore more publications!

Latest News

Labels On
FILTER THE FEED
Left-wing Center-left Neutral Public Broadcaster Gov't Institution Center-right Right-wing Pro-Government Gov't Propaganda Indeterminate
FILTER THE FEED
Source Label Filters

All labels are selected. Deselect any labels you want to hide from your feed.

Labels:

Left-wing
Center-left
Neutral
Public Broadcaster
Gov't Institution
Center-right
Right-wing
Pro-Government
Gov't Propaganda
Indeterminate

Vera Songwe appointed to Vatican’s Pontifical Academy of Social Sciences

Guinea-Bissau halts US-funded hepatitis B vaccine trial amid ethical concerns

Guinea-Bissau halts US-funded hepatitis B vaccine trial amid ethical concerns

Guinea-Bissau stops vaccine study funded by Trump administration

Guinea-Bissau stops vaccine study funded by Trump administration

Guinea-Bissau vaccine trial bucks precedent and international ethics standards, says WHO

Guinea-Bissau vaccine trial bucks precedent and international ethics standards, says WHO

The war on science is costing America its future

The war on science is costing America its future

WATCH | Guinea-Bissau stops vaccine study funded by Trump administration

WATCH | Guinea-Bissau stops vaccine study funded by Trump administration

WHO sets out concerns over US vaccine trial in G.Bissau

WHO sets out concerns over US vaccine trial in G.Bissau

Indeterminate Voice of Alexandria - Minnesota
Owner: Leighton Enterprises
Statement on the planned hepatitis B birth dose vaccine trial in Guinea-Bissau

Statement on the planned hepatitis B birth dose vaccine trial in Guinea-Bissau

Center-left The National Tribune
Owner: The National Tribune Australia

Vera Songwe appointed to Vatican’s Pontifical Academy of Social Sciences

Guinea-Bissau halts US-funded hepatitis B vaccine trial amid ethical concerns

Guinea-Bissau halts US-funded hepatitis B vaccine trial amid ethical concerns

Guinea-Bissau stops vaccine study funded by Trump administration

Guinea-Bissau stops vaccine study funded by Trump administration

Guinea-Bissau vaccine trial bucks precedent and international ethics standards, says WHO

Guinea-Bissau vaccine trial bucks precedent and international ethics standards, says WHO

The war on science is costing America its future

The war on science is costing America its future

WATCH | Guinea-Bissau stops vaccine study funded by Trump administration

WATCH | Guinea-Bissau stops vaccine study funded by Trump administration

UN agency recognizes 13 Guinea-Bissau communities as "FAO Villages"

WHO sets out concerns over US vaccine trial in G.Bissau

WHO sets out concerns over US vaccine trial in G.Bissau

Statement on the planned hepatitis B birth dose vaccine trial in Guinea-Bissau

Statement on the planned hepatitis B birth dose vaccine trial in Guinea-Bissau

Show More

Video Stories

YouTube video thumbnail: Transforming Africa: Which Essential Skills Will Define Africa's Future Workforce?
Play
Transforming Africa: Which Essential Skills Will Define Africa's Future Workforce?
YouTube video thumbnail: UN Envoy to the AU Visits Tanzania Following Post-Election Unrest
Play
UN Envoy to the AU Visits Tanzania Following Post-Election Unrest
YouTube video thumbnail: Israeli Billionaire's Firm Settles DR Congo Graft Probe for $30 Million
Play
Israeli Billionaire's Firm Settles DR Congo Graft Probe for $30 Million
YouTube video thumbnail: Drone Strike Hits Goma Killing aid Worker and Civilians
Play
Drone Strike Hits Goma Killing aid Worker and Civilians

Video Title

Press Releases

Macao Polytechnic University’s Internationalisation Project “MPU Connect” Shortlisted for QS Reimagine Education Awards

Macao Polytechnic University’s Internationalisation Project “MPU Connect” Shortlisted for QS Reimagine Education Awards

Macao Polytechnic University’s Internationalisation Project “MPU Connect” Shortlisted for QS Reimagine Education Awards

Macao Polytechnic University’s Internationalisation Project “MPU Connect” Shortlisted for QS Reimagine Education Awards

Show More
Your brand’s story is being written — with or without you.
We’re the leading press release service for mid-sized businesses & organizations built for the AI era.
Learn more

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions